Cellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDT

NEXT STORY
Kinross reports strong 2020 second-quarter results
PREV STORY
Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innate Pharma: Jennifer Butler appointed as Executive VP, General Manager, US

author_avatar
NASDAQ Market News

NuCana BioMed Limited: NuCana’s Acelarin achieves high clinical activity and durable disease control in patients with recurrent ovarian cancer

CHICAGO, June 6, 2016 (GLOBE NEWSWIRE) -- NuCana today presented positive interim results of ...

author_avatar
NASDAQ Market News

Dynavax Announces Publication of Two Papers in Leading Oncology Journal Highlighting Data From Clinical Studies of Its TLR9 Agonist, SD-101

Cancer Discovery Features Reports of Early Clinical Trials of SD-101 in Lymphoma and Advanced ...

author_avatar
NASDAQ Market News